Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations
Authors
Keywords
-
Journal
Pharmaceutics
Volume 15, Issue 1, Pages 99
Publisher
MDPI AG
Online
2022-12-28
DOI
10.3390/pharmaceutics15010099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
- (2022) Guilherme S. Ramos et al. Pharmaceutics
- Pharmacokinetics, biodistribution, and activity of Amphotericin B-loaded nanocochleates on the Leishmania donovani murine visceral leishmaniasis model
- (2022) Antonio Lipa Castro et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Amphotericin B: A drug of choice for Visceral Leishmaniasis
- (2022) Shobha Kumari et al. ACTA TROPICA
- Topical liposomal amphotericin B gel treatment for cutaneous leishmaniasis caused by Leishmania major: a double‐blind, randomized, placebo‐controlled, pilot study
- (2022) Amir Horev et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran
- (2022) Ali Khamesipour et al. EASTERN MEDITERRANEAN HEALTH JOURNAL
- Review of Novel Oral Amphotericin B Formulations for the Treatment of Parasitic Infections
- (2022) Ellen Wasan et al. Pharmaceutics
- Amphotericin B-loaded deformable lipid vesicles for topical treatment of cutaneous leishmaniasis skin lesions
- (2021) Manuela Carvalheiro et al. Drug Delivery and Translational Research
- Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections
- (2021) Francelise B. Cavassin et al. Infectious Diseases and Therapy
- Nanotechnology approaches for delivery and targeting of Amphotericin B in fungal and parasitic diseases
- (2021) Mahboobeh Jafari et al. Nanomedicine
- Host-Directed Therapies for Cutaneous Leishmaniasis
- (2021) Fernanda O. Novais et al. Frontiers in Immunology
- An appraisal of the scientific current situation and new perspectives in the treatment of cutaneous leishmaniasis
- (2021) C.A. Briones Nieva et al. ACTA TROPICA
- Skin penetration/permeation success determinants of nanocarriers: Pursuit of a perfect formulation
- (2021) Mohammed Elmowafy COLLOIDS AND SURFACES B-BIOINTERFACES
- Cochleate formulations of Amphotericin b designed for oral administration using a naturally occurring phospholipid
- (2021) Antonio Lipa-Castro et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Self-assembling, supramolecular chemistry and pharmacology of amphotericin B: Poly-aggregates, oligomers and monomers
- (2021) Raquel Fernández-García et al. JOURNAL OF CONTROLLED RELEASE
- American Cutaneous Leishmaniasis in French Guiana: a retrospective comparison between liposomal amphotericin B and meglumine antimoniate
- (2020) A. Senchyna et al. BRITISH JOURNAL OF DERMATOLOGY
- Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
- (2020) Faustino et al. Pharmaceutics
- Development of an Oral Amphotericin B Formulation as an Alternative Approach to Parenteral Amphotericin B Administration in the Treatment of Blood-Borne Fungal Infections
- (2020) Kishor M. Wasan CURRENT PHARMACEUTICAL DESIGN
- Nano-delivery systems for topical management of skin disorders
- (2020) Mingyue Cui et al. MOLECULAR PHARMACEUTICS
- Enhancing Safety and Efficacy by Altering the Toxic Aggregated State of Amphotericin B in Lipidic Nanoformulations
- (2020) Saugandha Das et al. MOLECULAR PHARMACEUTICS
- Preparation and Characterization of Nanostructured Lipid Carriers for Improved Topical Drug Delivery: Evaluation in Cutaneous Leishmaniasis and Vaginal Candidiasis Animal Models
- (2020) Amina Riaz et al. AAPS PHARMSCITECH
- Safety and tolerability of a novel oral formulation of amphotericin B: Phase I EnACT Trial
- (2020) Caleb Skipper et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety, tolerability, and pharmacokinetics of a novel oral amphotericin B formulation (iCo-019) following single-dose administration to healthy human subjects: An alternative approach to parenteral amphotericin B administration
- (2020) Peter Hnik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
- (2020) Parisa Ghasemiyeh et al. Drug Design Development and Therapy
- PEGylated nanoliposomes potentiated oral combination therapy for effective cancer treatment
- (2020) Archu Singh et al. Current Drug Delivery
- Recent advances and new strategies on leishmaniasis treatment
- (2020) Bruno Mendes Roatt et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Analytical method development and comparability study for AmBisome® and generic Amphotericin B liposomal products
- (2020) Yayuan Liu et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases
- (2020) Raquel Fernández-García et al. ACS Infectious Diseases
- Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance
- (2020) Hans Carolus et al. Journal of Fungi
- The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
- (2019) Grace Cuddihy et al. Pharmaceutics
- Critical process parameters in manufacturing of liposomal formulations of amphotericin B
- (2019) Benjamin Rivnay et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects
- (2019) Mahshid Mostafavi et al. BIOMEDICINE & PHARMACOTHERAPY
- Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases
- (2019) Juliane S. Lanza et al. Expert Opinion on Drug Delivery
- Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
- (2019) Mahmoud Reza Jaafari et al. International Journal for Parasitology-Drugs and Drug Resistance
- Liposomal Amphotericin B Treatment and the Leishmaniases
- (2019) Jonathan Berman AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes
- (2019) M. Junaid Dar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pharmacokinetics and tissue distribution of an orally administered mucoadhesive chitosan-coated amphotericin B-Loaded nanostructured lipid carrier (NLC) in rats
- (2019) Janet Sui Ling Tan et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- Circular dichroism in functional quality evaluation of medicines
- (2018) Han Yao et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome ® and AmBisome ® in murine cutaneous leishmaniasis
- (2018) Gert-Jan Wijnant et al. International Journal for Parasitology-Drugs and Drug Resistance
- Adapting liposomes for oral drug delivery
- (2018) Haisheng He et al. Acta Pharmaceutica Sinica B
- Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin B
- (2018) Gert-Jan Wijnant et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Leishmaniasis
- (2018) Sakib Burza et al. LANCET
- Liposomes can both enhance or reduce drugs penetration through the skin
- (2018) Ma. F. Peralta et al. Scientific Reports
- A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia
- (2018) Liliana López et al. PLoS Neglected Tropical Diseases
- Anti-leishmanial Nanotherapeutics: A Current Perspective
- (2018) Aditi Shah et al. CURRENT DRUG METABOLISM
- Development of a flow-through USP 4 apparatus drug release assay for the evaluation of amphotericin B liposome
- (2018) Jie Tang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Increasing the Fungicidal Action of Amphotericin B by Inhibiting the Nitric Oxide-Dependent Tolerance Pathway
- (2017) Kim Vriens et al. Oxidative Medicine and Cellular Longevity
- Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
- (2017) Romain Guery et al. PLoS Neglected Tropical Diseases
- Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro
- (2016) Ana Paula Perez et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Comparison between liposomal formulations of amphotericin B
- (2016) Jill P Adler-Moore et al. MEDICAL MYCOLOGY
- Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting
- (2016) Brian Palmer et al. MOLECULES
- Thermodynamics and kinetics of amphotericin B self-association in aqueous solution characterized in molecular detail
- (2016) Joanna Zielińska et al. Scientific Reports
- Molecular organization, localization and orientation of antifungal antibiotic amphotericin B in a single lipid bilayer
- (2016) Wojciech Grudzinski et al. Scientific Reports
- Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B
- (2015) Paulo R. L. Machado et al. CLINICAL INFECTIOUS DISEASES
- Nanoemulsions loaded with amphotericin B: A new approach for the treatment of leishmaniasis
- (2015) Leila Rodrigues Caldeira et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study
- (2015) Diego R. Falci et al. MYCOSES
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug
- (2014) Ana Cecilia Mesa-Arango et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments
- (2014) Daniel Michał Kamiński EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp
- (2014) Helga K. Ruiz et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Lipid nanoparticles: Drug localization is substance-specific and achievable load depends on the size and physical state of the particles
- (2014) Eva Kupetz et al. JOURNAL OF CONTROLLED RELEASE
- Complete Cure of Experimental Visceral Leishmaniasis with Amphotericin B in Stearylamine-Bearing Cationic Liposomes Involves Down-Regulation of IL-10 and Favorable T Cell Responses
- (2014) A. Banerjee et al. JOURNAL OF IMMUNOLOGY
- Self-Association of Amphotericin B: Spontaneous Formation of Molecular Structures Responsible for the Toxic Side Effects of the Antibiotic
- (2014) Joanna Starzyk et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Prodrug Strategies for Enhancing the Percutaneous Absorption of Drugs
- (2014) David N'Da MOLECULES
- Interactions of antileishmanial drugs with monolayers of lipids used in the development of amphotericin B–miltefosine-loaded nanocochleates
- (2013) T.T.H. Pham et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
- (2013) Richard J. Hamill DRUGS
- New strategy for enhancing the therapeutic index of Fungizone ®
- (2013) L. Belkherroubi-Sari et al. JOURNAL DE MYCOLOGIE MEDICALE
- Drug delivery systems for the topical treatment of cutaneous leishmaniasis
- (2012) Guilherme Carneiro et al. Expert Opinion on Drug Delivery
- Toward Understanding of Toxic Side Effects of a Polyene Antibiotic Amphotericin B: Fluorescence Spectroscopy Reveals Widespread Formation of the Specific Supramolecular Structures of the Drug
- (2012) Piotr Wasko et al. MOLECULAR PHARMACEUTICS
- Gelatin Coated Hybrid Lipid Nanoparticles for Oral Delivery of Amphotericin B
- (2012) Sanyog Jain et al. MOLECULAR PHARMACEUTICS
- Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a distigmasterylhemisuccinoyl-glycero-phosphocholine liposome-intercalated amphotericin B
- (2011) Maryam Iman et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- AmbiOnp: Solid Lipid Nanoparticles of Amphotericin B for Oral Administration
- (2011) Pratikkumar A. Patel et al. Journal of Biomedical Nanotechnology
- A newly identified derivative of amphotericin B: isolation, structure determination and primary evaluation of the activity and toxicity
- (2010) Yong-Hong Wang et al. JOURNAL OF ANTIBIOTICS
- A Novel Tropically Stable Oral Amphotericin B Formulation (iCo-010) Exhibits Efficacy against Visceral Leishmaniasis in a Murine Model
- (2010) Ellen K. Wasan et al. PLoS Neglected Tropical Diseases
- Highly Effective Oral Amphotericin B Formulation against Murine Visceral Leishmaniasis
- (2009) Kishor M. Wasan et al. JOURNAL OF INFECTIOUS DISEASES
- Pentavalent Antimonials: New Perspectives for Old Drugs
- (2009) Frédéric Frézard et al. MOLECULES
- Biodegradable Nanoparticles Improve Oral Bioavailability of Amphotericin B and Show Reduced Nephrotoxicity Compared to Intravenous Fungizone®
- (2009) J. L. Italia et al. PHARMACEUTICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now